Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 996.35B | 941.17B | 868.69B | 853.06B | 717.29B |
Gross Profit | 398.06B | 354.85B | 318.99B | 313.61B | 296.08B |
EBITDA | 182.67B | 164.01B | 153.11B | 128.23B | 217.96B |
Net Income | 130.11B | 80.01B | 72.78B | 62.25B | 150.58B |
Balance Sheet | |||||
Total Assets | 1.80T | 1.76T | 1.75T | 1.70T | 1.69T |
Cash, Cash Equivalents and Short-Term Investments | 428.09B | 571.03B | 524.47B | 455.08B | 483.44B |
Total Debt | 248.35B | 205.61B | 161.35B | 141.34B | 149.15B |
Total Liabilities | 714.12B | 652.23B | 630.12B | 613.36B | 606.58B |
Stockholders Equity | 1.01T | 986.54B | 989.66B | 948.48B | 937.47B |
Cash Flow | |||||
Free Cash Flow | 77.54B | 149.66B | 165.40B | 89.44B | 188.60B |
Operating Cash Flow | 163.51B | 182.59B | 199.75B | 142.76B | 231.79B |
Investing Cash Flow | -185.41B | -21.82B | -135.51B | -198.59B | -244.19B |
Financing Cash Flow | -76.22B | -108.24B | -65.62B | -64.45B | 30.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $2.37T | 33.98 | 24.77% | ― | 10.87% | 56.13% | |
79 Outperform | $282.66B | 15.76 | 13.04% | 1.65% | 5.17% | 74.55% | |
78 Outperform | $158.68B | 12.30 | 36.31% | ― | 35.04% | 22.04% | |
74 Outperform | $50.09B | 7.68 | 19.81% | 3.11% | 8.13% | 91.39% | |
73 Outperform | $87.39B | 103.80 | 11.13% | ― | 30.18% | 2034.24% | |
62 Neutral | $50.74B | 140.13 | 8.55% | ― | 18.69% | -65.55% | |
56 Neutral | HK$25.31B | 4.75 | -2.69% | 5.60% | -0.46% | -53.17% |